Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

772
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
772
Testing a Claim about Population Proportion01:24

Testing a Claim about Population Proportion

3.4K
A complete procedure for testing a claim about a population proportion is provided here.
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
3.4K
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

636
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
636
Testing a Claim about Mean: Unknown Population SD01:21

Testing a Claim about Mean: Unknown Population SD

3.6K
A complete procedure of testing a hypothesis about a population mean when the population standard deviation is unknown is explained here.
Estimating a population mean requires the samples to be approximately normally distributed. The data should be collected from the randomly selected samples having no sampling bias. There is no specific requirement for sample size. But if the sample size is less than 30, and we don't know the population standard deviation, a different approach is used;...
3.6K
Volume of Distribution01:20

Volume of Distribution

415
The apparent volume of distribution (Vd) is a crucial pharmacokinetic parameter representing the hypothetical body fluid volume into which a drug disperses. It is calculated based on the total amount of drug in the body (estimated from the administered dose and bioavailability) divided by the plasma drug concentration. The total amount of drug in the body does not directly refer to the dose given but is derived by accounting for absorption, distribution, metabolism, and excretion processes.
415
The Availability Heuristic01:08

The Availability Heuristic

6.3K
A heuristic is a general problem-solving framework (Tversky & Kahneman, 1974). You can think of these as mental shortcuts that are used to solve problems. Different types of heuristics are used in different types of situations, and the impulse to use a heuristic occurs when one of five conditions is met (Pratkanis, 1989):
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reference Range of Red Cell Distribution Width-to-Albumin Ratio in Healthy US Adults: A Cross-Sectional Study.

BioMed research international·2026
Same author

Association Between Red Blood Cell Distribution Width-To-Albumin Ratio and Breast, Colorectal, Lung, and Prostate Cancers.

Cancer medicine·2026
Same author

Revisiting the impact of common medications on immune checkpoint inhibitor efficacy.

Cancer·2026
Same author

Advancing ICOS agonism in solid tumors: lessons from INDUCE-1.

Journal for immunotherapy of cancer·2026
Same author

Uncertain use of a fixed p value significance threshold in randomized clinical trials.

Trials·2026
Same author

The <i>P</i> Value: What It Is and What It Is Not.

Journal of Korean medical science·2025
Same journal

Proteomics in myelodysplastic syndromes: towards novel prognostic and diagnostic biomarkers.

Biochemia medica·2026
Same journal

Cross-interference of hemolysis, icterus and lipemia: A study with real patient samples.

Biochemia medica·2026
Same journal

Factors associated with Gla-rich protein serum concentrations in healthy adults.

Biochemia medica·2026
Same journal

Homovanillic acid and vanillylmandelic acid as neuroblastoma biomarkers in children.

Biochemia medica·2026
Same journal

Verification of harmonized reference intervals in Croatia: is it time for a change?

Biochemia medica·2026
Same journal

Optimization of icterus interference thresholds for 45 parameters on the Atellica analyzers CH930 and IM1300.

Biochemia medica·2026
See all related articles

Related Experiment Video

Updated: Sep 5, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

523

The apparent prevalence, the true prevalence.

Farrokh Habibzadeh1, Parham Habibzadeh2, Mahboobeh Yadollahie3

  • 1Global Virus Network, Middle East Region, Shiraz, Iran.

Biochemia Medica
|July 8, 2022
PubMed
Summary
This summary is machine-generated.

Serologic tests often yield inaccurate results, making apparent prevalence differ from true disease prevalence. This study explains how to correct apparent prevalence using test accuracy metrics for reliable disease burden estimation.

Keywords:
diagnostic testsprevalencesensitivityseroepidemiologic studiesspecificity

More Related Videos

Comparative Analysis of Automatic Fecal Analyzer versus Direct Wet Smear Microscopy for Detecting Parasitic Infections in Stool Samples
04:57

Comparative Analysis of Automatic Fecal Analyzer versus Direct Wet Smear Microscopy for Detecting Parasitic Infections in Stool Samples

Published on: April 25, 2025

583
A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
09:35

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research

Published on: August 16, 2017

17.9K

Related Experiment Videos

Last Updated: Sep 5, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

523
Comparative Analysis of Automatic Fecal Analyzer versus Direct Wet Smear Microscopy for Detecting Parasitic Infections in Stool Samples
04:57

Comparative Analysis of Automatic Fecal Analyzer versus Direct Wet Smear Microscopy for Detecting Parasitic Infections in Stool Samples

Published on: April 25, 2025

583
A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
09:35

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research

Published on: August 16, 2017

17.9K

Area of Science:

  • Epidemiology
  • Biostatistics

Background:

  • Serologic tests are crucial for disease surveillance and prevalence studies.
  • Imperfect test accuracy leads to false positives and negatives, causing apparent prevalence to deviate from true prevalence.

Purpose of the Study:

  • To provide a method for deriving true disease prevalence from apparent prevalence.
  • To address the impact of uncertain test sensitivity and specificity on prevalence estimation.

Main Methods:

  • Mathematical derivation of true prevalence from apparent prevalence, sensitivity, and specificity.
  • Monte Carlo computer simulation to model uncertainty in test performance.
  • Analysis of a real-world case study.

Main Results:

  • Apparent prevalence is a biased estimator of true prevalence.
  • Correction methods can adjust for test inaccuracies.
  • Uncertainty in sensitivity and specificity further complicates accurate prevalence estimation.

Conclusions:

  • Apparent prevalence from serologic studies requires correction for accurate interpretation.
  • Understanding and accounting for test performance is essential for reliable epidemiological data.